<DOC>
	<DOCNO>NCT00855699</DOCNO>
	<brief_summary>Once someone become dependent alcohol ( alcoholic ) , risks complication alcohol withdrawal stop drinking grow . These include lifeâˆ’threatening fit delirium tremens ( see thing , become frightened ) . To prevent complication , people take medication benzodiazepine ( e.g. , valium librium ) reduce dos week ; call detoxification 'detox . ' In UK effective alcohol treatment exist little know best detox medication . Alternative drug benzodiazepine appear protect brain toxicity alcohol withdrawal reduce likelihood drinking . This study examine feasibility compare medication regimen alcohol detox first time primary care . It include standard detox regimen ( librium 8 day ) alone together drug , acamprosate , show reduce toxicity alcohol withdrawal preclinical model use detox help people remain sober . It focus practicality study well assess people feel ( withdrawal symptom ) ( drink first month ) .</brief_summary>
	<brief_title>Alcohol Detoxification Primary Care Treatment ( ADEPT )</brief_title>
	<detailed_description>Aims objective : To provide framework investigate hypothesis patient undergo alcohol detox primary care add acamprosate reduce regimen benzodiazepine ( chlordiazepoxide ) provide good symptom control detox compare benzodiazepine alone . In addition ass improvement sleep , drink outcome , completion rate cognitive performance . Specific primary aim : This feasibility study aim inform full application RCT compare effectiveness cost-effectiveness acamprosate adjunctive treatment benzodiazepine alcohol detox primary care . Key objective : 1. determine optimal method recruit patient primary care estimate likely recruitment rate 2. investigate feasibility completion variation propose primary outcome measure community - Clinical Institute Withdrawal Scale-Alcohol ( symptom detox ) , secondary outcome measure - drinking first month ( via diary derive % day abstinent ) , completion detox , sleep cognitive performance . 3. investigate patient GP acceptability randomise trial use qualitative measure .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>Anyone ( 1865 year old ) consult GP community base alcohol detox require medication appropriate . Due acamprosate 's license maintaining abstinence , nobody age 18 65 recruit . Unsuitable home/community detox , e.g. , current significant history : delirium tremens seizure current history high dose polydrug use significant medical psychiatric ill health pregnant breast feed Wernicke 's encephalopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Alcohol detoxification</keyword>
</DOC>